Yanjun Zhu

606 total citations
41 papers, 450 citations indexed

About

Yanjun Zhu is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Yanjun Zhu has authored 41 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 14 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Yanjun Zhu's work include Renal cell carcinoma treatment (21 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Ferroptosis and cancer prognosis (8 papers). Yanjun Zhu is often cited by papers focused on Renal cell carcinoma treatment (21 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Ferroptosis and cancer prognosis (8 papers). Yanjun Zhu collaborates with scholars based in China and United States. Yanjun Zhu's co-authors include Jianming Guo, Xiaoyi Hu, Jianghua Zheng, Tao Ding, Xianglai Xu, Jiaxi Yao, Wei Xi, Hang Wang, Hang Wang and Tongyu Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Yanjun Zhu

38 papers receiving 448 citations

Peers

Yanjun Zhu
C. Dittrich Austria
Ioanna Giopanou Greece
Hongda Lu China
Sarah Palackdharry United States
Georgia Demetriou South Africa
Maria Gabriella Malzone Italy
Shoji Hanada Japan
Zhibo Gao China
Shen Gu China
Wenxiang Ji China
C. Dittrich Austria
Yanjun Zhu
Citations per year, relative to Yanjun Zhu Yanjun Zhu (= 1×) peers C. Dittrich

Countries citing papers authored by Yanjun Zhu

Since Specialization
Citations

This map shows the geographic impact of Yanjun Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Zhu more than expected).

Fields of papers citing papers by Yanjun Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjun Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Zhu. The network helps show where Yanjun Zhu may publish in the future.

Co-authorship network of co-authors of Yanjun Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjun Zhu. A scholar is included among the top collaborators of Yanjun Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjun Zhu. Yanjun Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Tao, Lina He, Lei Xu, et al.. (2025). Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer. Chinese Journal of Cancer Research. 37(1). 90–114. 3 indexed citations
2.
Zhang, Bin, Dai Zeng, Pan Pan, et al.. (2025). A highly sensitive and selective rectilinearly π-extended NIR fluorescent rhodamine probe for Cu2+ detection in real food samples and fluorescence bioimaging in living cells and mice. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 340. 126310–126310.
3.
Zhu, Yanjun, Pan Pan, Bin Zhang, et al.. (2025). A highly sensitive near-infrared fluorescent probe for intelligent visual detection of Cu2+ in water/vegetables and bioimaging in vitro and in vivo. Dyes and Pigments. 243. 113033–113033. 1 indexed citations
4.
Wang, Jiajun, Xianglai Xu, Ying Wang, & Yanjun Zhu. (2025). Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. Cellular Oncology. 48(3). 775–787.
5.
Wang, Ying, et al.. (2024). Effect of galectin‐1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. Cancer Medicine. 13(7). e7113–e7113. 3 indexed citations
6.
7.
8.
9.
Xu, Peirong, Yaohui Li, Jiaqi Huang, et al.. (2022). Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study. Urologic Oncology Seminars and Original Investigations. 40(5). 199.e1–199.e8. 4 indexed citations
10.
Xu, Peirong, Jiaqi Huang, Yaohui Li, et al.. (2022). Prognostic value of tumour contour irregularity on surgical strategies for T1bN0M0 renal cell carcinoma: A multi-institutional study. European Journal of Radiology. 159. 110665–110665. 2 indexed citations
11.
Xu, Peirong, Jiaqi Huang, Yaohui Li, et al.. (2022). Does intraoperative cyst rupture of malignant cystic renal masses really have no negative impact on oncologic outcomes?. World Journal of Surgical Oncology. 20(1). 369–369. 4 indexed citations
12.
Ding, Tao, et al.. (2021). Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(6). 424–434. 1 indexed citations
13.
Ding, Tao, Yanjun Zhu, Huimin Jin, et al.. (2021). Circular RNA circ_0057558 Controls Prostate Cancer Cell Proliferation Through Regulating miR-206/USP33/c-Myc Axis. Frontiers in Cell and Developmental Biology. 9. 644397–644397. 32 indexed citations
14.
Lin, Tzu‐yin, Yanjun Zhu, Yuanpei Li, et al.. (2019). Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia. Nanomedicine Nanotechnology Biology and Medicine. 20. 102004–102004. 18 indexed citations
15.
Chen, Xiang, Jiaxi Yao, Li Liu, et al.. (2019). Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors. Targeted Oncology. 14(2). 187–195. 6 indexed citations
16.
Ding, Tao, Guihong Zhang, Zehuan Li, et al.. (2018). Circular RNA Expression Profiling Identifies Prostate Cancer- Specific circRNAs in Prostate Cancer. Cellular Physiology and Biochemistry. 50(5). 1903–1915. 68 indexed citations
17.
Zeng, Shuxiong, Yanjun Zhu, Ai-Hong Ma, et al.. (2017). The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer. Clinical Cancer Research. 23(21). 6580–6591. 44 indexed citations
18.
Mu, Yanling, et al.. (2016). Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway. SHILAP Revista de lepidopterología. 2 indexed citations
19.
Li, Yaohui, Lin Zhou, Yanjun Zhu, et al.. (2016). The zero ischemia index (ZII): a novel criterion for predicting complexity and outcomes of off-clamp partial nephrectomy. World Journal of Urology. 35(7). 1095–1102. 6 indexed citations
20.
Zhu, Yanjun, et al.. (2013). Hsa-mir-182 Downregulates RASA1 and Suppresses Lung Squamous Cell Carcinoma Cell Proliferation. Clinical Laboratory. 60(01/2014). 155–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Dittrich Breakdown of academic impact, for papers by Ioanna Giopanou Breakdown of academic impact, for papers by Hongda Lu Breakdown of academic impact, for papers by Sarah Palackdharry Breakdown of academic impact, for papers by Georgia Demetriou Breakdown of academic impact, for papers by Maria Gabriella Malzone Breakdown of academic impact, for papers by Shoji Hanada Breakdown of academic impact, for papers by Zhibo Gao Breakdown of academic impact, for papers by Shen Gu Breakdown of academic impact, for papers by Wenxiang Ji
Rankless by CCL
2026